As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S.
Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid ...
A Johnston County couple’s decades-long battle with cancer highlights the life-saving power of early detection and ...
Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash and cash equivalents of approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback